R&D

Japan Grants Orphan Status to QRX003 for Netherton Syndrome: Implications for Pharma Teams

MHLW · Netherton syndrome · 5 min

Lilly to Spotlight Growing Hematology Portfolio at 2026 EHA Annual Meeting: Key Data and Strategic Implications

EMA · 6 min

BBIA Joins EuropaBio: Strengthening the Bio-Based Economy for Pharma and Industry

4 min

Insights from ESMO Asia: Nadia Harbeck on Oncology Advances

FDA · oncology · 4 min

Kaléo's Initiative on Allergy Awareness: Amplifying Patient Stories

FDA · allergy · 5 min

EMA Horizon Scanning: Navigating Regulatory Updates for Future Medicines

FDA · 5 min

Arrowhead Pharmaceuticals Presents Positive Cardiometabolic Data at European A Meeting

FDA · Cardiometabolic disorders · 6 min

Florian Lordick Elected 2026 ESMO President: Implications for Global Oncology

FDA · oncology · 6 min

Favipiravir Shipment to Europe Signals Hantavirus Preparedness Amidst Cruise Ship Outbreak

hantavirus · 7 min

Quoin Pharmaceuticals Aims for First Peeling Skin Syndrome Trial with FDA IND Submission

FDA · 9 min

ENYO Pharma Appoints Jeff George as Chairman to Bolster Growth and Phase 3 Readiness for Vonafexor

Alport Syndrome · 7 min

Eli Lilly's 340B Policy Shift: Impact on Hospital Networks and Pharma Strategy

9 min